ResMed (RMD)
(Delayed Data from NYSE)
$244.94 USD
+1.96 (0.81%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $244.75 -0.19 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
ResMed (RMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$223.11 | $251.00 | $180.00 | -8.18% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for ResMed comes to $223.11. The forecasts range from a low of $180.00 to a high of $251.00. The average price target represents a decline of 8.18% from the last closing price of $242.98.
Analyst Price Targets (9 )
Broker Rating
ResMed currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.08 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, five are Strong Buy, representing 41.67% of all recommendations. A month ago, Strong Buy made up 41.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 6 |
Buy | 0 | 0 | 1 | 2 | 2 |
Hold | 6 | 7 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.17 | 2.08 | 2.04 | 1.96 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Not Identified | Not Identified | Hold | Strong Sell |
9/4/2024 | Needham & Company | Michael Matson | Moderate Buy | Hold |
8/5/2024 | UBS | Laura Sutcliffe | Hold | Hold |
8/2/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
8/2/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
8/2/2024 | Not Identified | Not Identified | Hold | Hold |
8/2/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
6/25/2024 | Not Identified | Not Identified | Strong Buy | Hold |
6/24/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.17 |
# of Recs in ABR | 12 |
Average Target Price | $223.11 |
LT Growth Rate | 11.30% |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 2.02 |
RMD FAQs
ResMed Inc. (RMD) currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for ResMed Inc. (RMD) is $223.11. The current on short-term price targets is based on 5 reports.
The forecasts for ResMed Inc. (RMD) range from a low of $180 to a high of $251. The average price target represents a decline of $8.91 from the last closing price of $244.94.
The current DOWNSIDE for ResMed Inc. (RMD) is 8.91%
Based on short-term price targets offered by nine analysts, the average price target for ResMed comes to $223.11. The forecasts range from a low of $180.00 to a high of $251.00. The average price target represents a decline of 8.18% from the last closing price of $242.98.